Switch theme
Sign up to access all valuation multiples
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
2012
459
LTM Revenue $183M
LTM EBITDA -$28.1M
-$73.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cronos Group has a last 12-month revenue (LTM) of $183M and a last 12-month EBITDA of -$28.1M.
In the most recent fiscal year, Cronos Group achieved revenue of $84.9M and an EBITDA of -$36.2M.
Cronos Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cronos Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $183M | XXX | $84.9M | XXX | XXX | XXX |
| Gross Profit | $55.6M | XXX | $18.2M | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 21% | XXX | XXX | XXX |
| EBITDA | -$28.1M | XXX | -$36.2M | XXX | XXX | XXX |
| EBITDA Margin | -15% | XXX | -43% | XXX | XXX | XXX |
| EBIT | -$68.7M | XXX | -$43.0M | XXX | XXX | XXX |
| EBIT Margin | -38% | XXX | -51% | XXX | XXX | XXX |
| Net Profit | $31.5M | XXX | $29.7M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 35% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cronos Group's stock price is CAD 3 (or $2).
Cronos Group has current market cap of CAD 1.1B (or $759M), and EV of -CAD 102M (or -$73.7M).
See Cronos Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$73.7M | $759M | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cronos Group has market cap of $759M and EV of -$73.7M.
Cronos Group's trades at -0.9x EV/Revenue multiple, and 2.0x EV/EBITDA.
Equity research analysts estimate Cronos Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cronos Group has a P/E ratio of 33.5x.
See valuation multiples for Cronos Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $759M | XXX | $759M | XXX | XXX | XXX |
| EV (current) | -$73.7M | XXX | -$73.7M | XXX | XXX | XXX |
| EV/Revenue | -0.6x | XXX | -0.9x | XXX | XXX | XXX |
| EV/EBITDA | 3.6x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBIT | 1.5x | XXX | 1.7x | XXX | XXX | XXX |
| EV/Gross Profit | -1.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 33.5x | XXX | 25.6x | XXX | XXX | XXX |
| EV/FCF | 2.9x | XXX | -17.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCronos Group's last 12 month revenue growth is 12%
Cronos Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cronos Group's rule of 40 is -71% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cronos Group's rule of X is 14% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cronos Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -15% | XXX | -43% | XXX | XXX | XXX |
| EBITDA Growth | -169% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -71% | XXX | -31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 14% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 72% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cronos Group acquired XXX companies to date.
Last acquisition by Cronos Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Cronos Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cronos Group founded? | Cronos Group was founded in 2012. |
| Where is Cronos Group headquartered? | Cronos Group is headquartered in Canada. |
| How many employees does Cronos Group have? | As of today, Cronos Group has 459 employees. |
| Who is the CEO of Cronos Group? | Cronos Group's CEO is Mr. Michael Gorenstein. |
| Is Cronos Group publicy listed? | Yes, Cronos Group is a public company listed on TSE. |
| What is the stock symbol of Cronos Group? | Cronos Group trades under CRON ticker. |
| When did Cronos Group go public? | Cronos Group went public in 2014. |
| Who are competitors of Cronos Group? | Similar companies to Cronos Group include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of Cronos Group? | Cronos Group's current market cap is $759M |
| What is the current revenue of Cronos Group? | Cronos Group's last 12 months revenue is $183M. |
| What is the current revenue growth of Cronos Group? | Cronos Group revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Cronos Group? | Current revenue multiple of Cronos Group is -0.6x. |
| Is Cronos Group profitable? | Yes, Cronos Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cronos Group? | Cronos Group's last 12 months EBITDA is -$28.1M. |
| What is Cronos Group's EBITDA margin? | Cronos Group's last 12 months EBITDA margin is -15%. |
| What is the current EV/EBITDA multiple of Cronos Group? | Current EBITDA multiple of Cronos Group is 3.6x. |
| What is the current FCF of Cronos Group? | Cronos Group's last 12 months FCF is -$35.1M. |
| What is Cronos Group's FCF margin? | Cronos Group's last 12 months FCF margin is -19%. |
| What is the current EV/FCF multiple of Cronos Group? | Current FCF multiple of Cronos Group is 2.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
